About Alpha Tau
Rethinking cancer care from the inside out.
Our Mission
Alpha TAU began with a simple but powerful insight: we believe that cancer patients should receive powerful therapy, delivered directly into the tumor, and without the harsh side effects.
The Unmet Need
In the current cancer treatment landscape, most types of cancer are treated by systemic therapies and external beam radiation. However, these therapies typically cause damage to the surrounding healthy tissue as well as to the cancer cells, potentially causing side effects. Plus, these therapies are often given in small doses and stretched over many cycles or fractions. We knew there had to be another way.
The Solution
With this insight, we developed the Alpha DaRT®, a technology designed to harness the naturally powerful properties of alpha particles to treat the tumor with precision, while potentially sparing nearby healthy cells. With the Alpha DaRT, our mission is to allow patients to receive an ultra-high dose of localized treatment in a single session with minimal side effects.
This is Our Purpose
Extending curative treatment beyond existing options
Targeting high-unmet-need cancers without effective current standards of care
A localized approach to amplify systemic treatment
Leadership
Board of Directors
Scientific Advisory Board
Honoring Professor Itzhak Kelson (1940 – 2025) co-inventor of Alpha DaRT and pioneer in applied physics and cancer care, remembered for his brilliance, humility, and warmth.
